Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides (original) (raw)

References

1. Saunders, A.M. et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467–1472 (1993).
   Article Google Scholar
2. Rebeck, G.W., Reiter, J.S., Strickland, D.K. & Hyman, B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575–580 (1993).
   Article Google Scholar
3. Strittmatter, W.J. et al. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098–8102 (1993).
   Article Google Scholar
4. Schmechel, D.E. et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649–9653 (1993).
   Article Google Scholar
5. Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17, 263–264 (1997).
   Article Google Scholar
6. Bales, K.R. et al. Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96, 15233–15238 (1999).
   Article Google Scholar
7. Holtzman, D.M. et al. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103, R15–R21 (1999).
   Article Google Scholar
8. Fagan, A.M. et al. Human and murine apoE markedly influence Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol. Dis. 9, 305–318 (2002).
   Article Google Scholar
9. Wyss-Coray, T. et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612–618 (2001).
   Article Google Scholar
10. Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat. Med. 6, 916–919 (2000).
    Article Google Scholar
11. Bacskai, B.J. et al. Non-Fc-mediated mechanisms are involved in clearance of amyloid-β in vivo by immunotherapy. J. Neurosci. 22, 7873–7878 (2002).
    Article Google Scholar
12. Frackowiak, J. et al. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta. Neuropathol. (Berl.) 84, 225–233 (1992).
    Article Google Scholar
13. Rogers, J., Strohmeyer, R., Kovelowski, C.J. & Li, R. Microglia and inflammatory mechanisms in the clearance of amyloid β peptide. Glia 40, 260–269 (2002).
    Article Google Scholar
14. Wisniewski, H.M., Wegiel, J., Wang, K.C., Kujawa, M. & Lach, B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16, 535–542 (1989).
    Article Google Scholar
15. Wisniewski, H.M., Wegiel, J. & Kotula, L. Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol. Appl. Neurobiol. 22, 3–11 (1996).
    Article Google Scholar
16. Wegiel, J. et al. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol. Aging 22, 49–61 (2001).
    Article Google Scholar
17. Meda, L. et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647–650 (1995).
    Article Google Scholar
18. Giulian, D. et al. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16, 6021–6037 (1996).
    Article Google Scholar
19. Qin, L. et al. Microglia enhance β-amyloid peptide–induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973–983 (2002).
    Article Google Scholar
20. Shao, Y. & McCarthy, K.D. Plasticity of astrocytes. Glia 11, 147–155 (1994).
    Article Google Scholar
21. Montgomery, D.L. Astrocytes: form, functions, and roles in disease. Vet. Pathol. 31, 145–167 (1994).
    Article Google Scholar
22. Hatten, M.E., Liem, R.R.M., Shelanset, M.L. & Mason, C.A. Astroglia in CNS injury. Glia 4, 233–243 (1991).
    Article Google Scholar
23. Al-Ali, S.Y. & Al-Hussain, S.M. An ultrastructural study of the phagocytic activity of astrocytes in adult rat brain. J. Anat. 188, 257–262 (1996).
    PubMed PubMed Central Google Scholar
24. Guillaume, D., Bertrand, P., Dea, D. & Poirier, J. Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform specific alterations. J. Neurochem. 66, 2410–2418 (1996).
    Article Google Scholar
25. Funato, H. et al. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain. Am. J. Pathol. 152, 983–992 (1998).
    PubMed PubMed Central Google Scholar
26. Matsunaga, W., Shirokawa, T. & Isobe, K. Specific uptake of Aβ1-40 in rat brain occurs in astrocyte, but not in microglia. Neurosci. Lett. 342, 129–131 (2003).
    Article Google Scholar
27. Wegiel, J., Wang, K.C., Tarnawsk, M. & Lach, B. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta. Neuropathol. (Berl). 100, 356–364 (2000).
    Article Google Scholar
28. Wyss-Coray, T. et al. Adult mouse astrocytes degrade amyloid-β in vitro and in situ. Nat Med. 9, 453–457 (2003).
    Article Google Scholar
29. Nitta, T., Yagita, H., Sato, K. & Okumura, K. Expression of Fc γ receptors on astroglial cell lines and their role in the central nervous system. Neurosurgery 31, 83–87 (1992).
    PubMed Google Scholar
30. Warshawsky, I., Bu, G. & Schwartz, A.L. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo. J. Clin. Invest. 92, 937–944 (1993).
    Article Google Scholar
31. Gylys, K.H., Fein, J.A., Tan, A.M. & Cole, G.M. Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-β protein into synaptic terminals. J. Neurochem. 84, 1442–1451 (2003).
    Article Google Scholar
32. Urmoneit, B. et al. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid β protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 77, 157–166 (1997).
    PubMed Google Scholar
33. Thal, D.R. et al. Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex. Acta. Neuropathol. 100, 608–617 (2000).
    Article Google Scholar
34. Yamaguchi, H., Sugihara, S., Ogawa, A., Saido, T.C. & Ihara, Y. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques. Acta. Neuropathol. 95, 217–222 (1998).
    Article Google Scholar
35. De Groot, C.J. et al. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J. Neurosci. Res. 49, 342–354 (1997).
    Article Google Scholar
36. Saura, J., Petegnief, V., Wu, X., Liang, Y. & Paul, S.M. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J. Neurochem. 85, 1455–1467 (2003).
    Article Google Scholar
37. Marr, R.A. et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23, 1992–1996 (2003).
    Article Google Scholar
38. Manders, E.E.M, Verbeek, F.J. & Aten, J.A. Measurement of co-localisation of objects in dual-colour images. J. Microsc. 169, 375–382 (1993).
    Article Google Scholar

Download references